Yüklüyor......
Cholinesterase inhibitors as Alzheimer's therapeutics
Alzheimer's disease (AD) is one of the most common forms of dementia. AD is a chronic syndrome of the central nervous system that causes a decline in cognitive function and language ability. Cholinergic deficiency is associated with AD, and various cholinesterase inhibitors have been developed...
Kaydedildi:
| Yayımlandı: | Mol Med Rep |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6625431/ https://ncbi.nlm.nih.gov/pubmed/31257471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10374 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|